HBM Healthcare Investments
Overview
HBM Healthcare Investments is a Swiss-based investment company that specializes in building and managing a globally diversified portfolio of private and public companies across the healthcare sector, including biotechnology, medical technology, diagnostics, and human medicine.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Fore Biotherapeutics | Jul 2026 | Series D-2 Extension | Co-investor |
| Lycia Therapeutics | Jun 2026 | Series D | Co-investor |
| CellCentric | May 2026 | Series D | Co-investor |
| Corxel | Jan 2026 | Series D Extension | Co-investor |
| Zhejiang Jixing Auto Parts Co., Ltd. | Jan 2026 | Series D Extension | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
